Cefixime for Diarrhea: Specific Indications
Cefixime tablets are indicated for bacterial diarrhea in specific pediatric populations: infants <3 months of age with suspected bacterial etiology, and children with bloody diarrhea who have neurologic involvement, based on local susceptibility patterns and travel history. 1
Clinical Context and Algorithmic Approach
When to Use Cefixime (Third-Generation Cephalosporin)
The 2017 IDSA guidelines provide clear direction on when third-generation cephalosporins like cefixime are appropriate:
For Bloody Diarrhea:
- Infants <3 months old with suspected bacterial etiology should receive empiric third-generation cephalosporin therapy 1
- Children with neurologic involvement (regardless of age) should receive third-generation cephalosporin as empiric therapy 1
- Choice depends on local antimicrobial susceptibility patterns and recent travel history
For Watery Diarrhea:
- Empiric antimicrobial therapy (including cefixime) is NOT recommended in most cases 1
- Exception: ill-appearing young infants who are immunocompromised may warrant consideration
Specific Pathogen Evidence
Research demonstrates cefixime's efficacy in specific bacterial diarrheas:
Shigellosis (Bacillary Dysentery):
- Cefixime (8 mg/kg/day once daily for 5 days) shows superior efficacy compared to ampicillin-sulbactam 2
- Shorter fever duration, reduced time to blood disappearance in stool, and decreased hospitalization time 2
- However, 2-day courses show higher bacteriologic failure rates (55%) versus 5-day courses (14%), despite similar clinical cure rates 3
Salmonella Enteritis:
- Critical caveat: Cefixime provides no clinical benefit in uncomplicated Salmonella enteritis 4
- Does not reduce duration of diarrhea, time to defervescence, or rate of bacterial clearance 4
- This aligns with guideline recommendations against routine antibiotic use for non-typhoidal Salmonella
Important Clinical Pitfalls
What NOT to Treat with Cefixime:
STEC/Shiga toxin-producing E. coli: Antimicrobials should be avoided in STEC O157 and other STEC producing Shiga toxin 2, as they may increase risk of hemolytic uremic syndrome 1
Uncomplicated watery diarrhea: No benefit in immunocompetent patients without recent international travel 1
Uncomplicated Salmonella gastroenteritis: Antibiotics do not improve outcomes and may prolong carrier state 4
FDA-Labeled Warnings:
Cefixime itself can cause Clostridium difficile-associated diarrhea (CDAD), which can range from mild diarrhea to fatal colitis 5. This paradoxical effect must be considered when prescribing for diarrheal illness.
Practical Dosing Algorithm
When cefixime IS indicated:
- Standard pediatric dose: 8 mg/kg/day once daily (maximum 400 mg/day)
- Duration: 5 days for shigellosis (shorter courses have higher bacteriologic failure) 3, 2
- Renal adjustment: Required for creatinine clearance <60 mL/min 5
Preferred alternatives in most cases:
- Adults with bloody diarrhea: Fluoroquinolone (ciprofloxacin) or azithromycin based on local resistance patterns 1
- Children with bloody diarrhea (>3 months, no neurologic signs): Azithromycin preferred over cephalosporins in most settings 1
The evidence strongly suggests cefixime has a narrow, specific role in pediatric bacterial diarrhea—primarily for very young infants and those with neurologic complications—rather than broad application across all diarrheal illnesses.